European Archives - Page 772 of 1168 - European Medical Journal

Gilteritinib Plus Azacitidine in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukaemia Patients Ineligible for Intensive Induction Chemotherapy: Preliminary Findings from the Safety Cohort

Search of more effective treatment for patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy remains challenging…

Retrospective Review of the Role of Abdominal Imaging in Evaluation of Cytopenias

Specifically, this study examines the use of abdominal imaging, via an ultrasound or CT scan, to identify the aetiology of haematologic abnormalities…

Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder that lessens the production of platelets. Despite treatments being available for ITP…

Resistant Bilateral Chylous Effusion as a Late Adverse Effect of Dasatinib Treatment in Chronic Myeloid Leukaemia

Dasatinib is a potent and efficacious second-generation oral tyrosine kinase inhibitor, frequently used for imatinib-resistant or intolerant BCR-ABL+…

Are Successful Pregnancies an Achievable Goal in Patients with Chronic Myeloid Leukaemia?

Currently, there is no evidence-based consensus for the management of CML in pregnancy; therefore, clinical observations have become very important…

A Review of the Different Haematological Parameters and Biomarkers Used for Diagnosis of Neonatal Sepsis

Even though there are recent sophisticated biomarkers to diagnose sepsis, it is still challenging to curtail sepsis mortality by timely intervention…

An interview with Susan Manber from Digitas Health

We recently met with Susan Manber, Chief Strategy Officer, Digitas Health, at the 2019 Cannes Lions Festival of Creativity…

Preventing the Atopic March Through Moisturising

MOISTURISER, particularly when used in the early stages of a child’s life, can help prevent the development of food allergies, hay fever, and asthma later…

Novel Immunotherapy for Bee Venom Shows Efficacy

SEVERE allergic reactions to bee venom can be more effectively prevented by a new vaccine containing a novel adjuvant called Advax, according to…

EMJ Nephrology 7.1 2019

EMJ Nephrology 7.1 presents a review of the distinguished 56th Annual European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)…